Naproxen sodium

Nomen		Naproxen sodium
Synonyma		(6R,7R)-7-[(Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylicacid;(6R,7R)-7α-[2-(2-Imino-4-thiazolin-4-yl )-2-[(Z)-methoxyimino]acetylamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid;Ceftizox;(7R)-7-[[ 2-(2-Aminothiazole-4-yl)-2-(methoxyimino)-1-oxChemicum albookoethyl]amino]cepham-3-ene-4-carboxylicacid;(7R)-7β-[2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetylamino]cepham-3-ene-4-carboxylicacid; Ceftizoxime (350mg)I0E262 0,999mg/mg(an);Ceftizoxime(350mg);(6R,7R)-7-[(2Z)-2-(2-aMino-1,3-thiazol-4-yl)-2- ]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
M
Formulae hypotheticae		C14H13O3.Na
M. Pondus		252.24
CAS Subcriptio Number		26159-34-2

Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum